Clinical Trials
53 trialsEvaluation of an Online Prostate Cancer Screening Decision Aid
Centers for Disease Control and Prevention
CaRPET
Washington D.C. Veterans Affairs Medical Center
VA STARPORT
VA Office of Research and Development
Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening
VA Office of Research and Development
SNARE
VA Office of Research and Development
A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging
VA Office of Research and Development
CHOMP
VA Office of Research and Development
ProGRESS
VA Office of Research and Development
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
VA Office of Research and Development
COBRA
VA Office of Research and Development
VA-BAT
VA Office of Research and Development
PROSPYL
VA Greater Los Angeles Healthcare System
Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
Centers for Disease Control and Prevention
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
VA Greater Los Angeles Healthcare System
Shared Decision Making: Prostate Cancer Screening
Centers for Disease Control and Prevention
A Yoga Program for Patients Undergoing Prostate Cancer Surgery
VA Office of Research and Development
Transpelvic Magnetic Stimulation to Improve Urogenital Function
VA Office of Research and Development
VD3PCa
VA Office of Research and Development
Ga68-PSMA-11
Harry S. Truman Memorial Veterans' Hospital
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
James J. Peters Veterans Affairs Medical Center
Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
Portland VA Medical Center
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
Portland VA Medical Center
ProsTel
VA Office of Research and Development
Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
VA Greater Los Angeles Healthcare System
PIVOT
VA Office of Research and Development
Role of Soy Supplementation in Prostate Cancer Development
VA Office of Research and Development
Optimizing Veteran-Centered Prostate Cancer Survivorship Care
VA Office of Research and Development
18F-DCFPyL PET-CT Scan and Prostate Cancer
VA Greater Los Angeles Healthcare System
Effect of Weight Loss on Prostate Cancer Pathology
VA Office of Research and Development
CAP
VA Office of Research and Development
Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy
Brooke Army Medical Center
vit D & PCa
VA Office of Research and Development
Statin Therapy Versus Placebo Prior to Prostatectomy
VA Office of Research and Development
External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate
U.S. Army Medical Research Acquisition Activity
PTV
U.S. Army Medical Research Acquisition Activity
Testing the Helpfulness of 2 Decision Aids for Prostate Cancer
VA Office of Research and Development
Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer
U.S. Army Medical Research Acquisition Activity
Treatment Decision Intervention for Veterans With Prostate Cancer
VA Office of Research and Development
Facilitating Shared Decisionmaking About Prostate Cancer Screening
VA Office of Research and Development
Early Stage Prostate Cancer Cohort
VA Office of Research and Development
IST 16167
Kansas City Veteran Affairs Medical Center
Study of Prostate Cancer in Black and White U.S. Veterans
VA Office of Research and Development
Calcifidol Therapy in Men With Cancer
VA Office of Research and Development
Tumor RNA Transfected Dendritic Cell Vaccines
VA Office of Research and Development
To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population.
VA Office of Research and Development
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
I-125 Versus Pd-103 for Low Risk Prostate Cancer
VA Puget Sound Health Care System
High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer
VA Puget Sound Health Care System
I-125 Versus Pd-103 for Medium Risk Prostate Cancer
VA Puget Sound Health Care System